| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.38 | 0.05 |